| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ludwig Institute for Cancer Research, Box 595, S-75124 Uppsala, Sweden
1Correspondence and current address: Division of Cellular Biochemistry, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. E-mail: ptdijke{at}nki.nl
Transforming growth factor-ß (TGF-ß) superfamily members are multifunctional cell–cell signaling proteins that play pivotal roles in tissue homeostasis and development of multicellular animals. They mediate their pleiotropic effects from membrane to nucleus through distinct combinations of type I and type II serine/threonine kinase receptors and their downstream effectors, known as Smad proteins. Certain Smads, termed receptor-regulated Smads, become phosphorylated by activated type I receptors and form heteromeric complexes with a common-partner Smad4, which translocates into the nucleus to control gene transcription. In addition to these signal transducing Smads, inhibitory Smads have been identified that inhibit the activation of receptor-regulated Smads. In contrast to the still growing TGF-ß superfamily (with ~30 members in mammals), relatively few type I and type II receptors as well as Smads have been identified. We will focus on recent insights into the molecular mechanisms by which signaling specificity between different TGF-ß superfamily members is achieved and regulated, and how a single family member can elicit a broad scala of biological responses.—Piek, E., Heldin, C.-H., ten Dijke, P. Specificity, diversity, and regulation in TGF-ß superfamily signaling.
Key Words: activin • bone morphogenetic protein • signal transduction • Smad • transforming growth factor-ß
This article has been cited by other articles:
|
|
 |
|
  E.-S. Akool, A. Doller, A. Babelova, W. Tsalastra, K. Moreth, L. Schaefer, J. Pfeilschifter, and W. Eberhardt Molecular Mechanisms of TGF{beta} Receptor-Triggered Signaling Cascades Rapidly Induced by the Calcineurin Inhibitors Cyclosporin A and FK506 J. Immunol., August 15, 2008; 181(4): 2831 - 2845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gratchev, J. Kzhyshkowska, S. Kannookadan, M. Ochsenreiter, A. Popova, X. Yu, S. Mamidi, E. Stonehouse-Usselmann, I. Muller-Molinet, L. Gooi, et al. Activation of a TGF-{beta}-Specific Multistep Gene Expression Program in Mature Macrophages Requires Glucocorticoid-Mediated Surface Expression of TGF-{beta} Receptor II J. Immunol., May 15, 2008; 180(10): 6553 - 6565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Saha, L. Ji, J. J. de Pablo, and S. P. Palecek TGF{beta}/Activin/Nodal Pathway in Inhibition of Human Embryonic Stem Cell Differentiation by Mechanical Strain Biophys. J., May 15, 2008; 94(10): 4123 - 4133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Dadlani, M. L. Ballinger, N. Osman, R. Getachew, and P. J. Little Smad and p38 MAP Kinase-mediated Signaling of Proteoglycan Synthesis in Vascular Smooth Muscle J. Biol. Chem., March 21, 2008; 283(12): 7844 - 7852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Velasco, P. Alvarez-Munoz, M. Pericacho, P. t. Dijke, C. Bernabeu, J. M. Lopez-Novoa, and A. Rodriguez-Barbero L- and S-endoglin differentially modulate TGF{beta}1 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts J. Cell Sci., March 15, 2008; 121(6): 913 - 919. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. P. Gaide Chevronnay, P. B. Cornet, D. Delvaux, P. Lemoine, P. J. Courtoy, P. Henriet, and E. Marbaix Opposite Regulation of Transforming Growth Factors-{beta}2 and -{beta}3 Expression in the Human Endometrium Endocrinology, March 1, 2008; 149(3): 1015 - 1025. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hirose, K. Nakazato, H. Song, and N. Ishii TGF- 1 and TNF-{alpha} are involved in the transcription of type I collagen {alpha}2 gene in soleus muscle atrophied by mechanical unloading J Appl Physiol, January 1, 2008; 104(1): 170 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. You, M. W. Bruinsma, T. How, J. H. Ostrander, and G. C. Blobe The type III TGF- receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation Carcinogenesis, December 1, 2007; 28(12): 2491 - 2500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. McReynolds, S. Gupta, M. E. Figueroa, M. C. Mullins, and T. Evans Smad1 and Smad5 differentially regulate embryonic hematopoiesis Blood, December 1, 2007; 110(12): 3881 - 3890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Renlund, F. H O'Neill, L. Zhang, Y. Sidis, and J. Teixeira Activin receptor-like kinase-2 inhibits activin signaling by blocking the binding of activin to its type II receptor J. Endocrinol., October 1, 2007; 195(1): 95 - 103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Cabello-Verrugio and E. Brandan A Novel Modulatory Mechanism of Transforming Growth Factor-beta Signaling through Decorin and LRP-1 J. Biol. Chem., June 29, 2007; 282(26): 18842 - 18850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-C. Poncelet, H. W. Schnaper, R. Tan, Y. Liu, and C. E. Runyan Cell Phenotype-specific Down-regulation of Smad3 Involves Decreased Gene Activation as Well as Protein Degradation J. Biol. Chem., May 25, 2007; 282(21): 15534 - 15540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bujak and N. G. Frangogiannis The role of TGF-{beta} signaling in myocardial infarction and cardiac remodeling Cardiovasc Res, May 1, 2007; 74(2): 184 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-A Seong, H. Jung, K.-T. Kim, and H. Ha 3-Phosphoinositide-dependent PDK1 Negatively Regulates Transforming Growth Factor-beta-induced Signaling in a Kinase-dependent Manner through Physical Interaction with Smad Proteins J. Biol. Chem., April 20, 2007; 282(16): 12272 - 12289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Andl, B. B. Fargnoli, T. Okawa, M. Bowser, M. Takaoka, H. Nakagawa, A. Klein-Szanto, X. Hua, M. Herlyn, and A. K. Rustgi Coordinated Functions of E-Cadherin and Transforming Growth Factor {beta} Receptor II In vitro and In vivo. Cancer Res., October 15, 2006; 66(20): 9878 - 9885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-Y. Bao, J. Yao, and Y.-F. Lee 1{alpha}, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis Carcinogenesis, September 1, 2006; 27(9): 1883 - 1893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Bangi and K. Wharton Dual function of the Drosophila Alk1/Alk2 ortholog Saxophone shapes the Bmp activity gradient in the wing imaginal disc Development, September 1, 2006; 133(17): 3295 - 3303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Mikami, J. H. Lim, H. Ishinaga, U.-H. Ha, H. Gu, T. Koga, H. Jono, H. Kai, and J.-D. Li The Transforming Growth Factor-beta-Smad3/4 Signaling Pathway Acts as a Positive Regulator for TLR2 Induction by Bacteria via a Dual Mechanism Involving Functional Cooperation with NF-{kappa}B and MAPK Phosphatase 1-dependent Negative Cross-talk with p38 MAPK J. Biol. Chem., August 4, 2006; 281(31): 22397 - 22408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q.-a. Yuan, H. H. Simmons, M. K. Robinson, M. Russeva, W. A. Marasco, and G. P. Adams Development of engineered antibodies specific for the Mullerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer. Mol. Cancer Ther., August 1, 2006; 5(8): 2096 - 2105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Camoretti-Mercado, D. J. Fernandes, S. Dewundara, J. Churchill, L. Ma, P. C. Kogut, J. F. McConville, M. S. Parmacek, and J. Solway Inhibition of Transforming Growth Factor beta-enhanced Serum Response Factor-dependent Transcription by SMAD7 J. Biol. Chem., July 21, 2006; 281(29): 20383 - 20392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Omori, K. Matsumoto, H. Sanjo, S. Sato, S. Akira, R. C. Smart, and J. Ninomiya-Tsuji TAK1 Is a Master Regulator of Epidermal Homeostasis Involving Skin Inflammation and Apoptosis J. Biol. Chem., July 14, 2006; 281(28): 19610 - 19617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Luo, E. Nieves, J. Kzhyshkowska, and R. H. Angeletti Endogenous Transforming Growth Factor-{beta} Receptor-mediated Smad Signaling Complexes Analyzed by Mass Spectrometry Mol. Cell. Proteomics, July 1, 2006; 5(7): 1245 - 1260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Farnworth, P. G. Stanton, Y. Wang, R. Escalona, J. K. Findlay, and G. T. Ooi Inhibins Differentially Antagonize Activin and Bone Morphogenetic Protein Action in a Mouse Adrenocortical Cell Line Endocrinology, July 1, 2006; 147(7): 3462 - 3471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Kim, S. Cho, S. Lee, K. H. Kim, K. H. Cho, H. C. Eun, and J. H. Chung Photoprotective and anti-skin-aging effects of eicosapentaenoic acid in human skin in vivo J. Lipid Res., May 1, 2006; 47(5): 921 - 930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ishida, T. Kondo, A. Kimura, K. Matsushima, and N. Mukaida Absence of IL-1 Receptor Antagonist Impaired Wound Healing along with Aberrant NF-{kappa}B Activation and a Reciprocal Suppression of TGF-beta Signal Pathway J. Immunol., May 1, 2006; 176(9): 5598 - 5606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tedgui and Z. Mallat Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways Physiol Rev, April 1, 2006; 86(2): 515 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bandyopadhyay, J. Fan, S. Guan, Y. Li, M. Chen, D. T. Woodley, and W. Li A "traffic control" role for TGF{beta}3: orchestrating dermal and epidermal cell motility during wound healing J. Cell Biol., March 27, 2006; 172(7): 1093 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G Farnworth, Y. Wang, P. Leembruggen, G. T Ooi, C. Harrison, D. M Robertson, and J. K Findlay Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins. J. Endocrinol., March 1, 2006; 188(3): 451 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Bobacz, R Ullrich, L Amoyo, L Erlacher, J S Smolen, and W B Graninger Stimulatory effects of distinct members of the bone morphogenetic protein family on ligament fibroblasts Ann Rheum Dis, February 1, 2006; 65(2): 169 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chen, M. Crawford, R. M. Day, V. R. Briones, J. E. Leader, P. A. Jose, and R. J. Lechleider RhoA Modulates Smad Signaling during Transforming Growth Factor-beta-induced Smooth Muscle Differentiation J. Biol. Chem., January 20, 2006; 281(3): 1765 - 1770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-A. Seong, H. Jung, H.-S. Choi, K.-T. Kim, and H. Ha Regulation of Transforming Growth Factor-beta Signaling and PDK1 Kinase Activity by Physical Interaction between PDK1 and Serine-Threonine Kinase Receptor-associated Protein J. Biol. Chem., December 30, 2005; 280(52): 42897 - 42908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.L. Tower, S.L. Chappell, K. Morgan, N. Kalsheker, P.N. Baker, and L.J. Morgan Transforming growth factor {beta}1 regulates angiotensin II type I receptor gene expression in the extravillous trophoblast cell line SGHPL-4 Mol. Hum. Reprod., December 1, 2005; 11(12): 847 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.-S. Akool, A. Doller, R. Muller, P. Gutwein, C. Xin, A. Huwiler, J. Pfeilschifter, and W. Eberhardt Nitric Oxide Induces TIMP-1 Expression by Activating the Transforming Growth Factor {beta}-Smad Signaling Pathway J. Biol. Chem., November 25, 2005; 280(47): 39403 - 39416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Dimitriadis, C.A. White, R.L. Jones, and L.A. Salamonsen Cytokines, chemokines and growth factors in endometrium related to implantation Hum. Reprod. Update, November 1, 2005; 11(6): 613 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Fernandez-L, F. Sanz-Rodriguez, R. Zarrabeitia, A. Perez-Molino, R. P. Hebbel, J. Nguyen, C. Bernabeu, and L.-M. Botella Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions Cardiovasc Res, November 1, 2005; 68(2): 235 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Vallier, M. Alexander, and R. A. Pedersen Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells J. Cell Sci., October 1, 2005; 118(19): 4495 - 4509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Moustakas and C.-H. Heldin Non-Smad TGF-{beta} signals J. Cell Sci., August 15, 2005; 118(16): 3573 - 3584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tang, V. Katuri, R. Srinivasan, F. Fogt, R. Redman, G. Anand, A. Said, T. Fishbein, M. Zasloff, E. P. Reddy, et al. Transforming Growth Factor-{beta} Suppresses Nonmetastatic Colon Cancer through Smad4 and Adaptor Protein ELF at an Early Stage of Tumorigenesis Cancer Res., May 15, 2005; 65(10): 4228 - 4237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Valcourt, M. Kowanetz, H. Niimi, C.-H. Heldin, and A. Moustakas TGF-{beta} and the Smad Signaling Pathway Support Transcriptomic Reprogramming during Epithelial-Mesenchymal Cell Transition Mol. Biol. Cell, April 1, 2005; 16(4): 1987 - 2002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Elliott and G. C. Blobe Role of Transforming Growth Factor Beta in Human Cancer J. Clin. Oncol., March 20, 2005; 23(9): 2078 - 2093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Runyan, H. W. Schnaper, and A.-C. Poncelet The Role of Internalization in Transforming Growth Factor {beta}1-induced Smad2 Association with Smad Anchor for Receptor Activation (SARA) and Smad2-dependent Signaling in Human Mesangial Cells J. Biol. Chem., March 4, 2005; 280(9): 8300 - 8308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gaedeke, T. Boehler, K. Budde, H.-H. Neumayer, and H. Peters Glomerular activin A overexpression is linked to fibrosis in anti-Thy1 glomerulonephritis Nephrol. Dial. Transplant., February 1, 2005; 20(2): 319 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Kamaraju and A. B. Roberts Role of Rho/ROCK and p38 MAP Kinase Pathways in Transforming Growth Factor-{beta}-mediated Smad-dependent Growth Inhibition of Human Breast Carcinoma Cells in Vivo J. Biol. Chem., January 14, 2005; 280(2): 1024 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kaivo-Oja, D. G. Mottershead, S. Mazerbourg, S. Myllymaa, S. Duprat, R. B. Gilchrist, N. P. Groome, A. J. Hsueh, and O. Ritvos Adenoviral Gene Transfer Allows Smad-Responsive Gene Promoter Analyses and Delineation of Type I Receptor Usage of Transforming Growth Factor-{beta} Family Ligands in Cultured Human Granulosa Luteal Cells J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 271 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yang, C. Dai, and Y. Liu A Novel Mechanism by which Hepatocyte Growth Factor Blocks Tubular Epithelial to Mesenchymal Transition J. Am. Soc. Nephrol., January 1, 2005; 16(1): 68 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. F. Schrijvers, A. S. De Vriese, and A. Flyvbjerg From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines Endocr. Rev., December 1, 2004; 25(6): 971 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Vicencio, C. G. Lee, S. J. Cho, O. Eickelberg, Y. Chuu, G. G. Haddad, and J. A. Elias Conditional Overexpression of Bioactive Transforming Growth Factor-{beta}1 in Neonatal Mouse Lung: A New Model for Bronchopulmonary Dysplasia? Am. J. Respir. Cell Mol. Biol., December 1, 2004; 31(6): 650 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G.M. Molin, R. E. Poelmann, M. C. DeRuiter, M. Azhar, T. Doetschman, and A. C. Gittenberger-de Groot Transforming Growth Factor {beta}-SMAD2 Signaling Regulates Aortic Arch Innervation and Development Circ. Res., November 26, 2004; 95(11): 1109 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. H. Lane, J. Sun, K. Devish, and W. J. Langer Dissociation of renal TGF-{beta} and hypertrophy in female rats with diabetes mellitus Am J Physiol Renal Physiol, November 1, 2004; 287(5): F1011 - F1020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Bakin, A. Safina, C. Rinehart, C. Daroqui, H. Darbary, and D. M. Helfman A Critical Role of Tropomyosins in TGF-{beta} Regulation of the Actin Cytoskeleton and Cell Motility in Epithelial Cells Mol. Biol. Cell, October 1, 2004; 15(10): 4682 - 4694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Takeda, F. Otsuka, K. Nakamura, K. Inagaki, J. Suzuki, D. Miura, H. Fujio, H. Matsubara, H. Date, T. Ohe, et al. Characterization of the Bone Morphogenetic Protein (BMP) System in Human Pulmonary Arterial Smooth Muscle Cells Isolated from a Sporadic Case of Primary Pulmonary Hypertension: Roles of BMP Type IB Receptor (Activin Receptor-Like Kinase-6) in the Mitotic Action Endocrinology, September 1, 2004; 145(9): 4344 - 4354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Henckaerts, J. C. Langer, J. Orenstein, and H.-W. Snoeck The Positive Regulatory Effect of TGF-{beta}2 on Primitive Murine Hemopoietic Stem and Progenitor Cells Is Dependent on Age, Genetic Background, and Serum Factors J. Immunol., August 15, 2004; 173(4): 2486 - 2493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Walker, K. S. Masters, D. N. Shah, K. S. Anseth, and L. A. Leinwand Valvular Myofibroblast Activation by Transforming Growth Factor-{beta}: Implications for Pathological Extracellular Matrix Remodeling in Heart Valve Disease Circ. Res., August 6, 2004; 95(3): 253 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Pioli, K. E. Goonan, K. Wardwell, and P. M. Guyre TGF-{beta} regulation of human macrophage scavenger receptor CD163 is Smad3-dependent J. Leukoc. Biol., August 1, 2004; 76(2): 500 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Sadlon, I. D. Lewis, and R. J. D'Andrea BMP4: Its Role in Development of the Hematopoietic System and Potential as a Hematopoietic Growth Factor Stem Cells, July 1, 2004; 22(4): 457 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Selvamurugan, S. Kwok, and N. C. Partridge Smad3 Interacts with JunB and Cbfa1/Runx2 for Transforming Growth Factor-{beta}1-stimulated Collagenase-3 Expression in Human Breast Cancer Cells J. Biol. Chem., June 25, 2004; 279(26): 27764 - 27773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Dai and Y. Liu Hepatocyte Growth Factor Antagonizes the Profibrotic Action of TGF-{beta}1 in Mesangial Cells by Stabilizing Smad Transcriptional Corepressor TGIF J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1402 - 1412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Rios, S. Fernandez-Nocelos, I. Carneiro, V. M. Arce, and J. Devesa Differential Response to Exogenous and Endogenous Myostatin in Myoblasts Suggests that Myostatin Acts as an Autocrine Factor in Vivo Endocrinology, June 1, 2004; 145(6): 2795 - 2803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. del Re, J. L. Babitt, A. Pirani, A. L. Schneyer, and H. Y. Lin In the Absence of Type III Receptor, the Transforming Growth Factor (TGF)-{beta} Type II-B Receptor Requires the Type I Receptor to Bind TGF-{beta}2 J. Biol. Chem., May 21, 2004; 279(21): 22765 - 22772. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Siddiqui, Z. K. Siddiqui, and A. B. Malik Albumin endocytosis in endothelial cells induces TGF-{beta} receptor II signaling Am J Physiol Lung Cell Mol Physiol, May 1, 2004; 286(5): L1016 - L1026. |
